Early nontumorous CT findings after irreversible electroporation of locally advanced pancreatic cancer
Authors:
- 28 June 2016
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 41 (11) , 2142-2149
Abstract
Purpose The use of irreversible electroporation (IRE) has been a relatively recent development in the palliative treatment of locally advanced pancreatic cancer. With CT as a key modality in patient follow-up, recognition of nontumorous imaging findings is paramount after IRE. Methods A retrospective review of patients having undergone IRE for locally advanced pancreatic adenocarcinoma was performed. A total of 36 patients met inclusion criteria and their imaging studies were reviewed by two radiologists. Nontumorous abnormalities identified in the peri-electroporation bed on Computed Tomography (CT) during the early postoperative period (within 30 days) were characterized and classified into categories. Results Our results indicate that the most common nontumorous findings in the peri-electroporation bed were vascular, followed by changes involving the gastrointestinal tract, peritoneal cavity, and, infrequently, the biliary tree. Conclusions Interpretation of CT imaging of the postoperative peri-electroporation bed is challenging. This review of CT findings allows the radiologist to recognize and anticipate significant nontumorous findings in the peri-electroporation bed during early follow-up after IRE.Keywords
This publication has 31 references indexed in Scilit:
- Irreversible electroporation of the pancreas: Definitive local therapy without systemic effectsJournal of Surgical Oncology, 2011
- Vascular Smooth Muscle Cells Ablation with Endovascular Nonthermal Irreversible ElectroporationJournal of Vascular and Interventional Radiology, 2010
- Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus StatementAnnals of Surgical Oncology, 2009
- Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus StatementAnnals of Surgical Oncology, 2009
- Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of DiseaseJournal of the American College of Surgeons, 2008
- Tumor Ablation with Irreversible ElectroporationPLOS ONE, 2007
- Trends in the Treatment and Outcome of Pancreatic Cancer in the United StatesAnnals of Surgical Oncology, 2007
- In Vivo Results of a New Focal Tissue Ablation Technique: Irreversible ElectroporationIEEE Transactions on Biomedical Engineering, 2006
- Tissue Ablation with Irreversible ElectroporationAnnals of Biomedical Engineering, 2005
- A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic CancerNew England Journal of Medicine, 2004